La Roche-Posay
La Roche-Posay is L'Oréal-owned dermocosmetics brand specializing in dermatologist-recommended skincare for sensitive skin, acne, hyperpigmentation, anti-aging, and sun protection, sold across mass, prestige, and DTC channels worldwide.
- Company typePrivate
- Founded1913
- HeadquartersBrooklyn, United States
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What La Roche-Posay does
La Roche-Posay is a dermocosmetics brand owned by L'Oréal S.A., specializing in skincare products formulated for sensitive skin and specific dermatological concerns. Its product portfolio is organized into clinically-positioned lines: Anthelios (broad-spectrum UV protection with proprietary Cell-Ox Shield), Toleriane (sensitive-skin moisturizers and cleansers with ceramides and niacinamide), Hyalu B5 (anti-aging with hyaluronic acid, Ectoin, and vitamin B5), Mela B3 (dark spot correction with proprietary Melasyl ingredient), Effaclar (acne treatment with salicylic acid and adapalene), Lipikar (body care for dry/eczema-prone skin), and Cicaplast (soothing/repair balms with vitamin B5+). The brand's signature formulation backbone is La Roche-Posay Thermal Spring Water, sourced from a thermal spring in France with a dermatological heritage dating to 1913. La Roche-Posay is recommended by 100,000 dermatologists worldwide and self-describes as the world's #1 dermocosmetics brand. The AI-powered MyRoutine skin analysis tool and Replenish & Save subscription program are the main DTC capabilities on laroche-posay.us. Products range from $15 to $55 per unit, with subscription discounts up to 15%.
The brand operates a multi-channel distribution model combining mass-market retail (Walmart at 1,460 U.S. stores, Target), prestige beauty (Sephora, Ulta Beauty), marketplaces (Amazon), and direct e-commerce. International operations extend to the UK (Wimbledon partnership), France (America's Cup K-Challenge Title Partner), India (launched November 2025 under L'Oréal India's Dermatological Beauty division), and China (spokesperson Sun Yingsha). La Roche-Posay monetizes exclusively through one-time product sales and subscription replenishment, supplemented by co-marketing-driven brand partnerships. Strategic partnerships in 2025-2026 include Illumination (Minions & Monsters), Keke Palmer (Mela B3 ambassador), Jannik Sinner (Global Brand Advocate for Anthelios), the Oncology Nursing Society (skin toxicity photo repository), and OpenAI (first-mover on GPT-Rosalind for skin microbiome mapping).
Revenue is not separately disclosed; La Roche-Posay is a wholly-owned brand within L'Oréal S.A.'s Dermatological Beauty division. L'Oréal reported €44.05 billion in full-year 2025 consolidated sales. The brand's competitive position is anchored in clinical credibility, dermatologist endorsement, proprietary ingredients, and L'Oréal's global scale, with recent offensive moves focused on U.S. mass-market channel expansion, India market entry, AI capability development, and high-profile sports and entertainment sponsorships.
La Roche-Posay firmographics
Firmographics- Name
- La Roche-Posay
- Legal name
- La Roche-Posay (Brand of L'Oréal)
- Website
- https://laroche-posay.us
- Company type
- Private
- Founded year
- 1913
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- La Roche-Posay is L'Oréal-owned dermocosmetics brand specializing in dermatologist-recommended skincare for sensitive skin, acne, hyperpigmentation, anti-aging, and sun protection, sold across mass, prestige, and DTC channels worldwide.
- Ownership category
- akta.pro rank
La Roche-Posay industry classification
Industry- Product category
- Dermocosmetics Skincare
- NAICS
- Cosmetics, Beauty Supplies, and Perfume Retailers (456120), Health and Personal Care Retailers (4561)
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
- akta.pro secondary industries
- Sensitive Skin & Barrier Repair (CRABAAAG), Treatment Skincare (Serums, Actives, Acne & Anti-aging) (CRABAAAB), Dermatology Specialty Pharmaceuticals (HLAIACAL), Professional Skincare & Facial Treatments (CRABALAF)
Keywords
Where La Roche-Posay is headquartered
LocationHeadquarters
- HQ city
- Brooklyn
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
La Roche-Posay business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Marketing or Sales, Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure
Revenue model
- Skincare Product Sales: Primary revenue stream from selling dermatological skincare products including moisturizers, serums, sunscreens, cleansers, and body care through retail partners and direct-to-consumer e-commerce. Products sold through Walmart (1,460 stores), Amazon, Ulta Beauty, Target, Sephora, and brand website.
- Professional/Medical Channel Sales: Revenue from pharmacist-delivered consultations at Walmart locations and partnerships with oncology care (Oncology Nursing Society) for cancer patient skin toxicity support.
- Brand Partnerships & Sponsorships: Co-marketing revenue through entertainment partnerships (Illumination Minions), sports sponsorships (America's Cup, Miami Open, Wimbledon), and brand ambassador collaborations that drive product sales.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Individual skincare products ranging from $15-$55 |
| Subscription | Monthly | Subscription with Replenish & Save program |
Go-to-market motion3 records
Distribution channels7 records
Marketing channels8 records
La Roche-Posay product offering
Product offeringCore offering
La Roche-Posay manufactures and sells dermatologist-recommended dermocosmetics skincare products formulated with Thermal Spring Water from La Roche-Posay, France. The portfolio spans Anthelios sun protection, Toleriane sensitive skin moisturizers, Hyalu B5 anti-aging, Mela B3 dark spot correction, Effaclar acne treatment, Lipikar body care, and Cicaplast soothing treatments, sold through mass-market retail, prestige beauty stores, e-commerce, and professional medical channels.
Product overview
La Roche-Posay is a derma-cosmetics brand owned by L'Oréal, specializing in dermatologist-recommended skincare products for sensitive skin. The brand operates as a unified product portfolio organized into distinct lines: Anthelios (sun protection with Cell-Ox Shield technology), Toleriane (moisturizers and cleansers with ceramide and niacinamide formulations), Hyalu B5 (anti-aging with hyaluronic acid and Vitamin B5), Mela B3 (dark spot correction with proprietary Melasyl ingredient), Lipikar (body care for dry skin), Cicaplast (therapeutic treatments with Vitamin B5+), and Effaclar (acne treatment with salicylic acid). The brand also offers an AI-powered MyRoutine Analysis tool for personalized recommendations and a refillable skincare sustainability initiative. Products are distributed through retail partnerships (Walmart, Amazon, Ulta, Target), the brand's direct website, and dermatologists, with recent expansion into 1,460 Walmart stores and the Indian market.
Differentiator
Problem solved
Functional benefit
Brands
- Anthelios: Sun protection product line featuring broad-spectrum UVA/UVB sunscreens including SPF 30-100+ formulations for face and body
- Toleriane
- Hyalu B5
- Effaclar
- Lipikar
- Cicaplast
- Mela B3
Products and services
- Anthelios Sunscreen Line Sun protection product line featuring broad-spectrum UVA/UVB defense with Cell-Ox Shield technology. Includes face sunscreens, mineral sunscreens, body sunscreens, sport sunscreens, tinted sunscreens, and kids formulations designed for sensitive skin.
- Toleriane Line Moisturizer and cleanser line designed for sensitive skin, featuring double repair technology with ceramides and niacinamide. Includes Toleriane Double Repair Face Moisturizer and Toleriane Hydrating Gentle Facial Cleanser.
- Hyalu B5 Line Anti-aging serum and moisturizer line featuring hyaluronic acid, Vitamin B5, and Ectoin. Includes Hyalu B5 Pure Hyaluronic Acid Serum and Hyalu B5 Suractivated Cream for hydration, firmness, and radiance.
- Mela B3 Line Dark spot correction line featuring proprietary Melasyl ingredient with 10% Niacinamide. Addresses hyperpigmentation and signs of aging. Includes Mela B3 Dark Spot Serum and Mela B3 Double Dose Discoloration Treatment.
- Lipikar Line
- Cicaplast Line Soothing therapeutic body care line featuring Vitamin B5+. Includes Cicaplast Balm B5+ for dry skin irritations and Cicaplast Hand Cream for dry/damaged hands.
- Effaclar Line Acne treatment line featuring salicylic acid and adapalene. Includes Effaclar Daily Acne Essentials Kit and Effaclar Multi-Target Acne Treatment for oily and acne-prone skin.
- MyRoutine AI Analysis Tool
- Refillable Skincare Program Refillable packaging program for select products offering reduced prices on refills, supporting environmental sustainability and reduced plastic waste for skincare consumers.
- Anthelios Light Fluid Facial Sunscreen SPF 60 Lightweight, oil-free, fragrance-free facial sunscreen with Cell-Ox Shield broad-spectrum UVA/UVB protection designed for sensitive skin.
Quantifiable outcome
- 94% of GLP-1 medication users felt Hyalu B5 regimen effectively addressed skin concerns after 4 weeks
- +4 more outcomes
Companies that use La Roche-Posay
Customer profileNamed customers4 records
Segments6 records
Ideal customer profiles6 records
La Roche-Posay technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature5 records
La Roche-Posay partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core, major and minor.
- OpenAIcoreL'Oréal's strategic AI collaboration with OpenAI (VivaTech 2026). La Roche-Posay is first brand to use OpenAI's GPT-Rosalind model for skin microbiome mapping to advance skincare development. L'Oréal has 73,000 employees trained in generative AI.
- Illumination EntertainmentmajorGlobal cinematic partnership for Minions & Monsters animated film (July 1, 2026 release). Co-branded campaign 'READY, CLEAR, ACTION!' launching June 1, 2026, leveraging Effaclar acne treatment range. Includes custom-animated Minions content. U.S. limited-edition Effaclar kits available through Ulta Beauty, Amazon, and brand website.
- Keke PalmermajorRenewed partnership as face of Mela B3 franchise (May 2026). Supporting launch of new Mela B3 Double Dose Discoloration Treatment. Campaign includes social media activations, educational content with dermatology experts, and exclusive cover launch with PAPER Magazine. Originally launched in 2024.
- Dr. Whitney BoweminorPartnership with dermatologist Dr. Whitney Bowe to create 'The Burning Truth: Debunking Myths About the Sun' public health documentary series (May 2026). Four-part series premiered during Melanoma Awareness Month to educate teens and young adults on sun safety.
- IMPACT MelanomaminorNonprofit organization endorsement for 'The Burning Truth' sun safety documentary series. Partnership supports public health education on melanoma prevention and sun safety.
- Jannik Sinnercore'Shadow Sponsor' campaign for sun protection awareness. Innovatively sponsors Sinner's shadow as a UV indicator to encourage protective behavior. Also Global Brand Advocate for Anthelios sun care range and supporter of Wimbledon partnership.
- WalmartmajorNationwide retail expansion launching La Roche-Posay in 1,460 Walmart stores. Walmart pharmacists trained as specialized skincare advisors providing personalized consultations including support for patients experiencing skin side effects from medical treatments. Products include Toleriane Double Repair, Anthelios Sunscreen SPF 60, and Hyalu B5 Serum.
- America's Cup (K-Challenge)majorTitle Partner of French Challenger team K-Challenge for 38th America's Cup. Competing as 'La Roche-Posay Racing Team' in America's Cup, Youth America's Cup, and Women's America's Cup. Partnership serves as 'living lab' to test skincare and sun protection formulas on athletes facing extreme conditions (UV, wind, salty waters). Preliminary regattas in Cagliari (May 2026), final in Naples (July 2027).
- Miami OpencoreExpanded sponsorship to become Official Skincare Partner in 2026. Shift from sun protection focus to total skin health awareness. Activities include on-site education and sun safety awareness for tennis fans and players.
- Oncology Nursing Society (ONS)coreLandmark partnership to develop skin toxicity photo repository tailored for diverse skin tones. Addresses significant educational gap as current materials lack representation of darker skin toxicities. Aims to improve cancer care for patients of color.
- The Championships, WimbledoncoreExclusive sun care supplier for Wimbledon (June 29 - July 12, 2026). Distributing over 500,000 sunscreen samples to visitors. Partnership aims to promote sun safety education amid rising UK melanoma rates (30% increase over past decade). Jannik Sinner supporting as Global Brand Advocate.
- Sun YingshacoreBrand spokesperson and global partner for serum & mask products. Chinese table tennis player ranked No. 1 in women's singles. Her reputation aligns with brand's focus on dermatological, safe, and effective skincare.
Scale indicators7 records
Recent moves11 records
Expansion highlights6 records
La Roche-Posay competitors and assessment
Company assessmentDirect peers
- CeraVe: L'Oréal-owned clinical skincare brand developed with dermatologists for sensitive, dry, and acne-prone skin. Most direct US competitor, often competing on the same retail shelves and dermatologist recommendations.
- Vichy Laboratoires: L'Oréal sister brand under the Dermatological Beauty division, anchored by Vichy Mineralizing Thermal Spring Water. Closely comparable on dermocosmetics positioning, sensitive-skin focus, and pharmacy-channel distribution.
- SkinCeuticals: L'Oréal Dermatological Beauty brand focused on advanced skincare backed by clinical research, particularly antioxidants and anti-aging. Comparable as a premium clinical skincare brand recommended by dermatologists.
- Eucerin: Beiersdorf-owned medical skincare brand specializing in sensitive, dry, and atopic skin. Comparable dermocosmetics positioning, dermatologist endorsement, and pharmacy/drugstore distribution footprint.
- Avène: Pierre Fabre dermocosmetics brand built around Avène Thermal Spring Water for sensitive skin. Highly comparable on thermal-spring-water heritage, sensitive-skin positioning, and pharmacy distribution.
- Bioderma: NAOS-owned French dermocosmetics brand focused on sensitive and reactive skin with pharmacy distribution. Comparable on dermatologist endorsement and dermo-cosmetic product portfolio.
- Cetaphil: Galderma-owned dermatologist-recommended skincare brand for sensitive skin. Direct competitor in cleansers, moisturizers, and sun care sold through mass and pharmacy channels.
Broad incumbents
- Neutrogena: Kenvue-owned mass-market skincare and sun-care brand with dermatologist positioning at much larger scale. Competes in the same sensitive-skin and sunscreen aisles but spans a broader mass audience.
Emerging players
- Drunk Elephant: Shiseido-owned clinical skincare brand built around biocompatible actives and clean formulations. Comparable on ingredient-led, dermatologist-adjacent positioning targeting a younger, premium consumer.
- The Ordinary: DECIEM (Estée Lauder) brand offering single-active skincare serums at accessible prices. Comparable as an actives-forward brand targeting acne, pigmentation, and anti-aging concerns but with a very different price architecture.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
La Roche-Posay social profiles
Digital presenceLa Roche-Posay financial estimates
Financial estimateRevenue estimate
Valuation estimate
La Roche-Posay leadership team
Management profileNumber of profiles
La Roche-Posay funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
La Roche-Posay M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about La Roche-Posay
What does La Roche-Posay do?
La Roche-Posay manufactures and sells dermatologist-recommended dermocosmetics skincare products formulated with Thermal Spring Water from La Roche-Posay, France. The portfolio spans Anthelios sun protection, Toleriane sensitive skin moisturizers, Hyalu B5 anti-aging, Mela B3 dark spot correction, Effaclar acne treatment, Lipikar body care, and Cicaplast soothing treatments, sold through mass-market retail, prestige beauty stores, e-commerce, and professional medical channels.
Is La Roche-Posay a public or private company?
La Roche-Posay is a private company. It is classified as corporate owned and is currently operating.
When was La Roche-Posay founded?
La Roche-Posay was founded in 1913. It employs 11 to 50 people.
Where is La Roche-Posay based?
La Roche-Posay is headquartered in Brooklyn, United States, in the North America region.
How does La Roche-Posay make money?
Three revenue lines are on record. Skincare Product Sales are the primary driver. The others are professional/Medical Channel Sales and brand Partnerships & Sponsorships.
Who are La Roche-Posay's main competitors?
Direct peers on record are CeraVe, Vichy Laboratoires, SkinCeuticals, Eucerin, Avène, Bioderma and Cetaphil. Neutrogena is listed as a broad incumbent. Emerging players are Drunk Elephant and The Ordinary.
Does La Roche-Posay have an API?
No public API is recorded for La Roche-Posay.
What industry is La Roche-Posay in?
La Roche-Posay's product category is Dermocosmetics Skincare. Its primary akta.pro industry code is CRABAAAF, Dermocosmetics & Medical-Grade Skincare, with a secondary code of CRABAAAG, Sensitive Skin & Barrier Repair. Its NAICS code is 456120 and its SIC code is 2844.